N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity:: Part I
被引:327
作者:
Thorneloe, Kevin S.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Thorneloe, Kevin S.
[1
]
Sulpizio, Anthony C.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Sulpizio, Anthony C.
[1
]
Lin, Zuojun
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Lin, Zuojun
[1
]
Figueroa, David J.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Figueroa, David J.
[1
]
Clouse, Angela K.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Clouse, Angela K.
[1
]
McCafferty, Gerald P.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
McCafferty, Gerald P.
[1
]
Chendrimada, Tim P.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Chendrimada, Tim P.
[1
]
Lashinger, Erin S. R.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Lashinger, Erin S. R.
[1
]
Gordon, Earl
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Gordon, Earl
[1
]
Evans, Louise
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Evans, Louise
[1
]
Misajet, Blake A.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Misajet, Blake A.
[1
]
DeMarini, Douglas J.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Collegeville, PA USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
DeMarini, Douglas J.
[2
]
Nation, Josephine H.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Transgen Genotyping & Viral Vectors, Harlow, Essex, EnglandGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Nation, Josephine H.
[3
]
Casillas, Linda N.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Collegeville, PA USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Casillas, Linda N.
[2
]
Marquis, Robert W.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Collegeville, PA USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Marquis, Robert W.
[2
]
Votta, Bartholomew J.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Collegeville, PA USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Votta, Bartholomew J.
[2
]
Sheardown, Steven A.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Transgen Genotyping & Viral Vectors, Harlow, Essex, EnglandGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Sheardown, Steven A.
[3
]
Xu, Xiaoping
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Xu, Xiaoping
[1
]
Brooks, David P.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Brooks, David P.
[1
]
Laping, Nicholas J.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Laping, Nicholas J.
[1
]
Westfall, Timothy D.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USAGlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
Westfall, Timothy D.
[1
]
机构:
[1] GlaxoSmithKline, Cardiovasc & Urogenital Ctr Excellence Drug Disco, King Of Prussia, PA 19406 USA
[2] GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Collegeville, PA USA
[3] GlaxoSmithKline, Transgen Genotyping & Viral Vectors, Harlow, Essex, England
The transient receptor potential (TRP) vanilloid 4 (TRPV4) member of the TRP superfamily has recently been implicated in numerous physiological processes. In this study, we describe a small molecule TRPV4 channel activator, (N-((1S)-1-{[4-((2S)-2{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl] carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), which we have used as a valuable tool in investigating the role of TRPV4 in the urinary bladder. GSK1016790A elicited Ca2+ influx in mouse and human TRPV4-expressing human embryonic kidney (HEK) cells (EC50 values of 18 and 2.1 nM, respectively), and it evoked a dose-dependent activation of TRPV4 whole-cell currents at concentrations above 1 nM. In contrast, the TRPV4 activator 4 alpha-phorbol 12,13-didecanoate (4 alpha-PDD) was 300-fold less potent than GSK1016790A in activating TRPV4 currents. TRPV4 mRNA was detected in urinary bladder smooth muscle (UBSM) and urothelium of TRPV4(+/+) mouse bladders. Western blotting and immunohistochemistry demonstrated protein expression in both the UBSM and urothelium that was absent in TRPV4(-/-) bladders. TRPV4 activation with GSK1016790A contracted TRPV4(+/+) mouse bladders in vitro, both in the presence and absence of the urothelium, an effect that was undetected in TRPV4(-/-) bladders. Consistent with the effects on TRPV4 HEK whole-cell currents, 4 alpha-PDD demonstrated a weak ability to contract bladder strips compared with GSK1016790A. In vivo, urodynamics in TRPV4(+/+) and TRPV4(-/-) mice revealed an enhanced bladder capacity in the TRPV4(-/-) mice. Infusion of GSK1016790A into the bladders of TRPV4(+/+) mice induced bladder overactivity with no effect in TRPV4(-/-) mice. Overall TRPV4 plays an important role in urinary bladder function that includes an ability to contract the bladder as a result of the expression of TRPV4 in the UBSM.